RECENT NEWS

For the third year in a row the challenges facing the UK’s HealthTech industry have continued to grow, the latest sector-wide study has revealed. Following a year marked by regulatory uncertainties and persistent, increasing barriers, the industry, which employs over 150,000 people, finds itself at a critical juncture.

Learna has announced a new partnership with the University of Wolverhampton to offer new Master's and Postgraduate Diploma programmes in Acute and Urgent Care, Diabetes, Healthcare Leadership, Medical Education, and Primary Care.

Research commissioned by Roche and carried out across 12 countries in Latin America and Europe has revealed that half of those polled have either limited or no awareness of the important role human papillomavirus (HPV) plays in cervical cancer.

The Association of British HealthTech Industries (ABHI), in partnership with the Department for Business and Trade (DBT), is proud to launch the first-ever UK Pavilion at Africa Health Exhibition, the continent’s largest healthcare event.

A new partnership between Roche Diagnostics UK and Ireland, Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, will play a key role in developing cutting-edge medical diagnostics.

Women with worrying lumps are to be directly referred to a breast diagnostic clinic using the NHS App as part of a new trial, the Health and Social Care Secretary has announced. The hope is that this will lead to faster diagnosis for cancer patients and free up more GP appointments.

NHS maternity staff in England will take part in a new pilot programme to help reduce avoidable brain injuries in childbirth, the government has announced.

The Royal College of Pathologists (RCPath) is marking International Pathology Day on Wednesday 6 November with a day-long virtual conference looking at the issue of antimicrobial resistance (AMR).

The National Pathology Imaging Co-operative (NPIC) at Leeds Teaching Hospitals NHS Trust will receive £5.1 million from the Government to improve data infrastructure that will aid cancer and disease research – potentially leading to faster and more accurate diagnosis of cancer and other diseases.

Adsilico, a ground-breaking computational modelling company working with medical simulation and generative AI, recently completed a £3.5 million seed round investment, and now announces its first Chair, Chris Richardson.

The Medical Defence Union (MDU) has announces it’s sponsorship of the upcoming NHS Parliamentary Awards ceremony, which will be held in Westminster on Monday 14 October 2024.

Gloucestershire Hospitals NHS Foundation Trust has successfully gone live with Altera’s Sunrise Knowledge-based Medication Administration (KBMA) system, across all adult inpatient wards. This move enhances patient safety with closed-loop medicine administration and will accelerate digital maturity towards the HIMSS Electronic Medical Record Adoption Model (EMRAM) stage 6 target.

Clinicians working at five of the six trusts in the West Yorkshire Association of Acute Trusts (WYAAT) can access test results from across their pathology network, following a summer roll-out of Clinisys’ ICE OpenNet.

A new type of blood test using lipids could make it easier to identify children at risk of complications around obesity including type two diabetes, liver and heart disease, say scientists.

A Liberal Democrats survey says one in four people have avoided calling an ambulance because they thought it would take too long to arrive.

Hundreds of babies have begun to be tested for over 200 rare genetic conditions as part of a world-leading study in NHS hospitals that aims to screen up to 100,000 newborns in England.

DrDoctor, a leading patient engagement platform (PEP) supplier, has announced a new partnership with Countess of Chester Hospital NHS Foundation to empower operational and clinical teams to manage and scale hybrid patient pathways within the trust.

​Tens of thousands of children and eligible adults living with type 1 diabetes across England are set to receive an ‘artificial pancreas’ thanks to cost-effective deals secured by the NHS with suppliers of the technology.

​A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that patients may benefit if doctors stop calling certain early-stage changes to the prostate 'cancer'.

Speaking at the Future Surgery event in London today, Tim Mitchell, President of the Royal College of Surgeons of England, warned the Government it will ‘fail to make a sufficient dent in reducing waiting times without investment in crumbling NHS infrastructure and new technology’.